On January 25, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma" during a live webinar. The recorded webinar and presentation slides are available below.
Webinar Faculty:
The webinar discussed:
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.
This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.Please note that the on-demand webinar is not available for continuing education credits#Lymphoma #RecordedWebinar #PresentationSlides #ClinicalPracticeGuideline #Clinician #NursePractitioner #Pharmacist #PrimaryCarePhysician #RegisteredNurse #2021 #ClinicalTrials #AdoptiveCellTherapy #AntibodyDrugConjugates #ImmuneCheckpointInhibitors #TherapeuticAntibodies #AdverseEvents
Meeting: SITC Clinical Practice Guideline Webinar – Immunotherapy for the Treatment of Lymphoma; Faculty: Stephen M. Ansell, MD, PhD – Mayo Clinic Cancer Center; Michael R. Bishop, MD – University of Chicago; Sattva S. Neelapu, MD – The University of Texas MD Anderson Cancer Center; Date: January 25, 202100:58:02